Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa
FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa
FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa
Submitted by
admin
on February 22, 2012 - 10:12pm
Source:
Washington Post, DC
News Tags:
FDA
Vivus
obesity
Qnexa
advisory panel
Headline:
FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa
Do Not Allow Advertisers to Use My Personal information
